DS

Daisuke Suzuki

Active Director Director DIN 12027721
DIN 12027721 First appointment Oct 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Daisuke Suzuki

Daisuke Suzuki is a Director at Nsk Medical India Private Limited (since 2026).

DIN 12027721
Primary Designation Director
First Appointment 30 Oct 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nsk Medical India Private Limited U46596KA2026FTC230503
Director30 Oct 20262026Active

Board colleagues of Daisuke Suzuki

NameDINCompanyDesignation
Hiroaki YoshidaNsk Medical India Private LimitedNon- Individual Subscriber
Hiroaki Yoshida12027720Nsk Medical India Private LimitedDirector
Rajan Das Gupta01324228Nsk Medical India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nsk Medical India Private Limited
Premium access

Shareholding and investment profile for Daisuke Suzuki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daisuke Suzuki

Daisuke Suzuki currently holds 1 directorship: Nsk Medical India Private Limited (Director, since 30 Oct 2026).

Daisuke Suzuki was first appointed on 30 Oct 2026 as Director at Nsk Medical India Private Limited.

The current boards of Daisuke Suzuki's companies include Hiroaki Yoshida (Nsk Medical India Private Limited), Hiroaki Yoshida (Nsk Medical India Private Limited), Rajan Das Gupta (Nsk Medical India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available